Company / Assets per Share
Cogent Biosciences, Inc. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.27
FY2025
5-year range
$3.16 / $7.27
FY2021-FY2025
Trend
+130.4%
vs FY2024
Sector context
#119 of 210
Health Care
What the data says
At $7.27, Cogent Biosciences, Inc.'s assets per share ranks #119 of 210 in the Health Care sector. Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $7.27.
Based on SEC 10-K filings.
7.27 in FY2025 with a 5-year CAGR of -20.3%.
Improved from $3.93 to $7.27 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Sector benchmark
#119 of 210 in Health CareTop 57% of 210This company $7.27 Sector average $352.89
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 130.4% year-over-year.
- Ranks #119 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.27 | +130.4% |
| FY2024 | $3.16 | -19.8% |
| FY2023 | $3.93 | -23.2% |
| FY2022 | $5.12 | -14.5% |
| FY2021 | $5.99 | -73.5% |
| FY2020 | $22.64 | +249.1% |
| FY2019 | $6.49 | +87.9% |
| FY2018 | $3.45 | -28.4% |
| FY2017 | $4.82 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026